Background illustration for clinical trials search

Paid Clinical Trials Daytona Beach

Discover 861 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

for
PTSD - Post Traumatic Stress Disorder, PTSD, PTSD Symptoms,
Location: Orlando FL, New York NY
Sponsor: COMPASS Pathways

Sex: All

Age: 18+

Code: NCT07570654

Phase2, Phase3, Recruiting

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: Orlando FL, West Palm Beach FL, Savannah GA,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Orlando FL, Tampa FL, Miami Gardens FL, Charlotte NC,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07196501

Phase3, Recruiting

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

for
Tardive Dyskinesia
Location: Orlando FL, Jacksonville FL, Gainesville FL, Tampa FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT03062033

Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Orlando FL, Ocala FL, Kissimmee FL, Jacksonville FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Orlando FL, Gainesville FL, Fort Lauderdale FL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase3, Recruiting

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

for
Peripheral Nerve Injury Upper Limb,
Location: Orlando FL, Charleston SC, Atlanta GA, New Orleans LA,
Sponsor: Neuraptive Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT06616025

Phase3, Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

for
Obesity, Overweight, Chronic Weight Management,
Location: Leesburg FL, Ocoee FL, Ocala FL, Clearwater FL,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07654374

Phase3, Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

for
SLE, SLE (Systemic Lupus)
Location: Orlando FL, Memphis TN, Webster TX, New York NY,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18 - 70

Code: NCT06613360

Phase1, Recruiting

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

for
Ulcerative Colitis
Location: Orlando FL, Cleveland OH, Royal Oak MI, Chicago IL,
Sponsor: Pfizer

Sex: All

Age: 12 - 17

Code: NCT05287126

Phase2, Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Orlando FL, Atlanta GA, Durham NC, Nashville TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase1, Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Orlando FL, Durham NC, Denver CO, Nashville TN,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase1, Recruiting

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor
Location: Orlando FL, Sarasota FL, Plantation FL, Tamarac FL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05785741

Phase1, Phase2, Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

for
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung,
Location: Orlando FL, Nashville TN, Baltimore MD, Houston TX,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT06131840

Phase1, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Orlando FL, Birmingham AL, Tyler TX, Chicago IL,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase1, Phase2, Recruiting

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

for
Solid Tumor, Adult
Location: Orlando FL, Sarasota FL, Nashville TN, Pittsburgh PA,
Sponsor: Ribon Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04053673

Phase1, Recruiting

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: Orlando FL, Atlanta GA, Huntersville NC, Nashville TN,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase1, Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, Dallas TX, San Antonio TX,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07372625

Phase1, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

for
Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer,
Location: Orlando FL, Nashville TN, Houston TX
Sponsor: Phrontline Biopharma

Sex: All

Age: 18+

Code: NCT07181473

Phase1, Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: Orlando FL, Jacksonville FL, Denver CO, Nashville TN,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase1, Recruiting